Evotec SE SEC filings

Filings

1. 6-KEvotec SEEVOTF4d

   Evotec SE names new CSO

   • Appointed Dr. Joanna Holbrook as CSO
   • Added to Management Board
   • Date: October 15, 2026
2. SCHEDULE 13D/AEvotec SEEVOTF4d

   Evotec SE: Mubadala sells all shares

   • Mubadala sold all 11,481,502 Ordinary Shares on 10/9/2026
   • Mubadala sold 1 ADS on 10/9/2026
   • Mubadala previously owned 9,182,652 Ordinary Shares and 4,597,701 ADSs

   Mubadala Investment Co PJSC, filed by

3. 6-KEvotec SEEVOTF5d

   Evotec SE reports 2026 results above expectations

   • Preliminary nine-month 2026 revenues of ~465M
   • Adjusted EBITDA of ~-42.8M
   • Full-year 2026 revenue guidance of 570-610M
4. 6-KEvotec SEEVOTFSep 29

   Foreign issuer report

5. 6-KEvotec SEEVOTFSep 9

   Foreign issuer report

6. 6-KEvotec SEEVOTFAug 13

   Foreign issuer report

7. 6-KEvotec SEEVOTFJun 30

   Foreign issuer report

8. 6-KEvotec SEEVOTFJun 17

   Foreign issuer report

9. 6-KEvotec SEEVOTFMay 6

   Foreign issuer report

10. SCHEDULE 13D/AEvotec SEEVOTFMay 1

    Ownership stake disclosure by MAK Capital Fund LP (amended)

    MAK Capital Fund LP, filed by

11. 6-KEvotec SEEVOTFApr 30

    Foreign issuer report

12. 6-KEvotec SEEVOTFApr 24

    Foreign issuer report

13. 6-KEvotec SEEVOTFApr 8

    Foreign issuer report

14. 20-FEvotec SEEVOTFApr 8

    Annual report

15. 6-KEvotec SEEVOTFApr 7

    Foreign issuer report

16. SCHEDULE 13D/AEvotec SEEVOTFApr 6

    Ownership stake disclosure by MAK Capital Fund LP (amended)

    MAK Capital Fund LP, filed by

17. SCHEDULE 13DEvotec SEEVOTFMar 30

    Ownership stake disclosure by MAK Capital Fund LP

    MAK Capital Fund LP, filed by

18. 6-KEvotec SEEVOTFMar 10

    Foreign issuer report

19. SCHEDULE 13G/AEvotec SEEVOTFFeb 17

    Ownership stake disclosure by Novo Holdings A/S (amended)

    Novo Holdings A/S, filed by

20. 6-KEvotec SEEVOTFJan 16

    Foreign issuer report

21. SCHEDULE 13GEvotec SEEVOTFJan 16

    Ownership stake disclosure by MAK Capital Fund LP

    MAK Capital Fund LP, filed by

22. 6-KEvotec SEEVOTFJan 16

    Foreign issuer report

23. 6-KEvotec SEEVOJan 13

    Foreign issuer report

24. 6-KEvotec SEEVOTFJan 6

    Foreign issuer report

25. 6-KEvotec SEEVOTFJan 2

    Foreign issuer report

26. 6-KEvotec SEEVOTFJan 2

    Foreign issuer report

27. 6-KEvotec SEEVOTFDec 8, 2025

    Foreign issuer report

28. SCHEDULE 13G/AEvotec SEEVOTFNov 14, 2025

    Novo Holdings A/S filed a Schedule 13G/A disclosing a 5.01% ownership stake in Evotec SE, a leading drug discovery and development company. This regulatory filing indicates Novo Holdings has maintained a significant investment position in Evotec, signaling continued confidence…

    Novo Holdings A/S, filed by

29. 6-KEvotec SEEVOTFNov 6, 2025

    Foreign issuer report

30. 6-KEvotec SEEVOTFNov 5, 2025

    Foreign issuer report

31. 6-KEvotec SEEVOTFNov 5, 2025

    Foreign issuer report

Older filings on EDGAR